UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 157

Sortiert nach

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients

Nature communications, 2021-11, Vol.12 (1), p.6774-6774, Article 6774

2021

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies

Clinical microbiology reviews, 2022-09, Vol.35 (3), p.e0022721

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis

Scientific reports, 2024-03, Vol.14 (1), p.7407-7407, Article 7407

2024

Link zum Volltext

Verfügbarkeit prüfen

Learning from COVID-19 to reimagine tuberculosis diagnosis

The Lancet. Microbe, 2021-05, Vol.2 (5), p.e169-e170

2021

Link zum Volltext

Verfügbarkeit prüfen

IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions

Expert review of molecular diagnostics, 2012-03, Vol.12 (2), p.175-187

2012

Link zum Volltext

Verfügbarkeit prüfen

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection

Scientific reports, 2015-03, Vol.5 (1), p.9223-9223, Article 9223

2015

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care diagnosis of tuberculosis: Past, present and future

Respirology (Carlton, Vic.), 2013-02, Vol.18 (2), p.217-232

2013

Link zum Volltext

Verfügbarkeit prüfen

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial

PloS one, 2018-09, Vol.13 (9), p.e0204554-e0204554

2018

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review

PloS one, 2021-05, Vol.16 (5), p.e0251236-e0251236

2021

Link zum Volltext

Verfügbarkeit prüfen

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial

American journal of respiratory and critical care medicine, 2019-01, Vol.199 (2), p.220-231

2019

Link zum Volltext

Verfügbarkeit prüfen

Economic analysis of different throughput scenarios and implementation strategies of computer-aided detection software as a screening and triage test for pulmonary TB

PloS one, 2022-12, Vol.17 (12), p.e0277393-e0277393

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania

PloS one, 2021-06, Vol.16 (6), p.e0252808-e0252808

2021

Link zum Volltext

Verfügbarkeit prüfen

Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis

Scientific reports, 2017-06, Vol.7 (1), p.2830-11, Article 2830

2017

Link zum Volltext

Verfügbarkeit prüfen

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection

PloS one, 2021-12, Vol.16 (12), p.e0261442-e0261442

2021

Link zum Volltext

Verfügbarkeit prüfen

Perspective for Precision Medicine for Tuberculosis

Frontiers in immunology, 2020-10, Vol.11, p.566608

2020

Link zum Volltext

Verfügbarkeit prüfen

Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail

PloS one, 2018-07, Vol.13 (7), p.e0201629-e0201629

2018

Link zum Volltext

Verfügbarkeit prüfen

TB incidence in an adolescent cohort in South Africa

PloS one, 2013-03, Vol.8 (3), p.e59652-e59652

2013

Link zum Volltext

Verfügbarkeit prüfen

IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting

Scientific reports, 2019-03, Vol.9 (1), p.3871-3871, Article 3871

2019

Link zum Volltext

Verfügbarkeit prüfen

Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho

PloS one, 2023-03, Vol.18 (3), p.e0278653-e0278653

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers

PloS one, 2013-03, Vol.8 (3), p.e58202

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial

The lancet respiratory medicine, 2017-04, Vol.5 (4), p.259-268

2017

Link zum Volltext

Verfügbarkeit prüfen

Oral swabs with a rapid molecular diagnostic test for pulmonary tuberculosis in adults and children: a systematic review

The Lancet global health, 2024-01, Vol.12 (1), p.e45-e54

2024

Link zum Volltext

Verfügbarkeit prüfen

Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria

EBioMedicine, 2020-12, Vol.62, p.103117-103117, Article 103117

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(156)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(91)
Humans
(82)
Tuberculosis
(77)
Infectious Diseases
(43)
Female
(38)
Tuberculosis - Diagnosis
(38)
Mycobacterium Tuberculosis
(36)
Male
(35)
Adult
(32)
Microbiology
(32)
Immunology
(31)
Respiratory System
(26)
Multidisciplinary Sciences
(25)
Science & Technology - Other Topics
(25)
Diagnosis
(23)
Adolescent
(21)
Infections
(21)
Middle Aged
(21)
Hiv
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients

Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies

Author Correction: Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis

Learning from COVID-19 to reimagine tuberculosis diagnosis

IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection

Point-of-care diagnosis of tuberculosis: Past, present and future

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial

Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial

Economic analysis of different throughput scenarios and implementation strategies of computer-aided detection software as a screening and triage test for pulmonary TB

Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania

Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection

Perspective for Precision Medicine for Tuberculosis

Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail

TB incidence in an adolescent cohort in South Africa

Prospective multicentre accuracy evaluation of the FUJIFILM SILVAMP TB LAM test for the diagnosis of tuberculosis in people living with HIV demonstrates lot-to-lot variability

IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting

Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho

Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial

Oral swabs with a rapid molecular diagnostic test for pulmonary tuberculosis in adults and children: a systematic review

Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria

Suchergebnisse filtern